Silent Hypoxemia from COVID-19 Explained
Spoon Feed
The severe, yet clinically silent, hypoxemia of COVID-19 seen in some patients may be explained by a few basic respiratory pathophysiological principles.
June 2020
Does Syncope in PE Mean Increased Mortality?
Spoon Feed
PE with syncope is associated with increased risk of short-term mortality, which is explained by the increase in hemodynamic instability seen in these patients as well.
Major Consensus Statement on IV Contrast Nephropathy
Spoon Feed
This is a summary of the major ACR/NKF consensus statements.
Oral Nitroglycerin for Food Impaction
Spoon Feed
Oral nitroglycerin didn’t seem to be particularly effective for esophageal food impaction in this small, non-blinded single arm study. Only 11.8%, or 2/17 patients, had relief of their symptoms after NTG administration.
Aortic Dissection Detection Risk Score – Is It Clinically Useful?
Spoon Feed
The aortic dissection detection risk score (ADD-RS) is sensitive at a score of ≥1. Adding a D-dimer to the score improves sensitivity even more but at the cost of a slightly lower specificity.
DOSE VF – Dual Sequential Defibrillation RCT
Spoon Feed
This small pilot study suggests that vector change defibrillation and double sequential external defibrillation are safe and feasible for termination of refractory ventricular fibrillation and improves the rate of ROSC.
Is Vitamin K Needed for INR Over 10?
Spoon Feed
In asymptomatic patients with INR>10, vitamin K administration was not associated with improved clinical outcomes.
Ten Evidence-Based Countermeasures for Night Shift Workers
Spoon Feed
To improve safety for patients and the health of night shift workers, implement these personal and institutional countermeasures.
An Easy Way to Debunk False Penicillin Allergies?
Spoon Feed
In both an outpatient clinic and ICU population, patients deemed to have low risk penicillin allergies who underwent direct oral challenge of amoxicillin had no reported adverse effects.
Haloperidol for Headache – THE HA Study RCT
Spoon Feed
In patients aged 15 to 55 years with benign headaches, low dose IV haloperidol (2.5mg) improved pain in as little as 30 minutes without significant adverse events such as QT prolongation.